Výsledky vyhledávání - "Asma, Hadjeb"

Poster: MPN-076 Impact of Comorbidities and Response to Treatment on the MPN SAF Assessment of Philadelphia Chromosome–Negative Myeloproliferative Syndromes

Autor: Amina Ramdoun, Asma Hadjeb, Malika Chereti, Soraya Benichou, Zahia Zouaoui, Sidi Mohamed El Amine Benlazar

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 22:S156

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bbf675acf09d65b1801b5ef6327983fa
https://doi.org/10.1016/s2152-2650(22)00957-0

Zobrazit plný text záznamu

CML-068 Impact of Low Grade Effects of Tyrosine Kinase Inhibitors on the Quality of Life of Patients Treated for Chronic Myeloid Leukemia

Autor: Sidi Mohamed El Amine Benlazar, Asma Hadjeb, Naima Zemri, Fouzia Ouadah, Najet Siali, Zahia Zouaoui

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 22:S286

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c57f12f4def4efddb667ab7da886b080
https://doi.org/10.1016/s2152-2650(22)01361-1

Zobrazit plný text záznamu

Poster: CML-068 Impact of Low Grade Effects of Tyrosine Kinase Inhibitors on the Quality of Life of Patients Treated for Chronic Myeloid Leukemia

Autor: Sidi Mohamed El Amine Benlazar, Asma Hadjeb, Naima Zemri, Fouzia Ouadah, Najet Siali, Zahia Zouaoui

Publikováno v: Clinical Lymphoma Myeloma and Leukemia. 22:S147

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0a032a0d7ceae00f5192c869e78bc3cd
https://doi.org/10.1016/s2152-2650(22)00889-8

Zobrazit plný text záznamu

Predictors Factors of Death during Induction Therapy of Acute Myeloblastic Leukemias (Western Algeria, multicenter experience)

Autor: Benkhira Nadjia, Zouaoui Zahia, Chekkaf Ismahane, Brahim Benzineb, Hadj Touhami, Othman Ibraheem, A Bachiri, Djamel Saidi, Asma Hadjeb, Mohamed Aberkane, Mohammed Amine Bekadja, Bendahmane Ahmed Fouad, Amina Krim, Mesli Naima, Samira Zouani, N Mehalhal, Faiza Bensmail

Publikováno v: Blood. 132:5189-5189

Introduction: Death during induction therapy remains a problem in the management of acute myeloid leukemia (AML). An estimated 6.1% in adult patients and between 19.3% and 27% in subjects of all ages have died of AML during induction therapy. The pur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9636317e098e1cae5e33f3674771bc4a
https://doi.org/10.1182/blood-2018-99-112430

Zobrazit plný text záznamu

Hodgkin Lymphoma in the West of Algeria: Panorama of Characteristics, Initial Work-up, Survival and Risk Factors Distribution

Autor: Amine Ma Bekadja, Naima Mesli, Hadj Touhami, Fatiha Mekkous-Touhami, Z Zouaoui, A Bachiri, Asma Hadjeb, Nadia Houti, Tamim Alsuliman, R. Bouhass, Abdessamed Arabi, N Mehalhal

Publikováno v: Journal of Blood & Lymph.

Introduction: The principal object of this study is to represent - in maximum accuracy- the real status of Hodgkin’s lymphoma in west of Algeria, we think also it serves as an adequate indicator for the epidemiological characteristics of HL patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd958ae58991e7c502be02fc2378f968
https://doi.org/10.4172/2165-7831.1000120

Zobrazit plný text záznamu